Genmab — Marts 2021
-
3 weeks max till we hear from fda about tiso
-
Would be nice with some real news. GEN has not been pampering us lately...
-
also hoping to get Tepezza production back up in the next few weeks.... https://twitter.com/Quantumup1/status/1372531505818431490
-
Wow - look at that range on the 2021 revenue expectations!!
-
Spørgsmål til Q&A er meget velkommen.
-
E L. Should Genmab help them and buy a ....
-
@Plimsoller blocked !
-
True, but along the way between then and now, it could have resulted in bankruptcy. It is forgotten
-
In the end, I think the whole thing was written off - and the sales amount was very close to zero. The real cost was the diversion from the core business of Genmab - development of new drugs
-
Purchase price usd 240m - sales price usd 10m....
-
...there is a hole in that business model, but I can’t seem to put my finger on it....
-
But I’m guessing the real lesson was Zalu falling flat on it’s stomach - hope we will not see similar things with the programs we retain ownership over in the years to come
-
I think it is fair to expect a few failures in the years to come, like Enapotamab failed. The art will be to detect them early before they cost too much... disappointments happen, but Genmab's hit-ratio is high so far, making me realistically optimistic
-
@Stockbull 01:44, så havde M.Lykketoft måske alligevel ret dengang (-:
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind